What is LOPJLB’s current signal on VVOS?

LOPJLB’s latest quantitative signal on Vivos Therapeutics, Inc. (VVOS) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is VVOS in?

Vivos Therapeutics, Inc. (VVOS) is currently classified in the CRISIS HMM market regime on LOPJLB.

Where is Vivos Therapeutics, Inc. based / listed?

Vivos Therapeutics, Inc. is based in US, listed on NASDAQ.

Vivos Therapeutics, Inc. (VVOS)

COMPARE

Healthcare · Medical - Devices · NASDAQ · US

$0.15+0.00%Close

SELLCRISIS · day 47

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $883,428
Beta: 6.07
P/E (TTM): -0.07

Short % float: 89.72%
Days to cover: 1.0
SI change: +76.1%

1W: +0.00%
1M: -16.67%

vs SPY 1W: -1.16%
vs SPY 1M: -19.66%

Industry peers

FMP comparable companies · ranked by market cap

ANLSELLAdlai Nortye Ltd.$768MRECOVERYQ 15$14.46+0.71%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Company

Vivos Therapeutics, Inc. operates as a medical technology company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical,…

Employees: 268
Headquarters: US
Founded: 2020
Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Devices
Shares out: 5.9M
Float: 54.2%

vivos.com ↗

Key executives

R. Kirk Huntsman — Co-Founder, Chairman of the Board & Chief Executive Officer

Bradford K. Amman — Chief Financial Officer, Treasurer & Secretary

Susan McCullough — Co-Founder & Executive Vice President of Operations

SEC filings

EDGAR · CIK 17161660 · VVOS

Analyst consensus

Buy

Bullish6100.0%

Neutral00.0%

Bearish00.0%

L $1.75Avg $2.13H $2.50

Target$2.13+1320.00%

Last$0.15

Key stats

Industry peers

Prediction markets

Company news